新型N-取代苯甲酰基-N′-(4-甲基苯并噻唑-2-基)硫脲衍生物的合成、晶体结构及抑菌活性

以取代苯甲酸和2-氨基-4-甲基苯并噻唑为原料合成5个新型N-取代苯甲酰基-N′-(4-甲基苯并噻唑-2-基)硫脲衍生物,化合物结构经元素分析、IR、1 H NMR和13 C NMR表征,X-射线单晶衍射测定了N-(4-甲氧苯甲酰基)-N′-(4-甲基苯并噻唑-2-基)硫脲(化合物1)的晶体结构,该晶体为单斜晶系,P21/c空间群,选择广西主要经济作物中常见的病原菌,对目标化合物进行室内抑菌活性测试,实验结果发现该类化合物具有一定的抑菌活性.     

5-(2-羟基苯基)-1,3,4-噻二唑-2-硫基乙酰腙化合物的合成及抑菌活性

以2-巯基-5-(2-羟基苯基)-1,3,4-噻二唑为原料,经硫醚化、肼解、腙化反应合成了9个5-(2-羟基苯基)-1,3,4-噻二唑-2-硫基乙酰腙化合物,其结构由1H NMR,13C NMR,IR,MS表征和元素分析,并初步研究了目标化合物的抑菌活性.结果表明它们大多数具有优良的抑菌活性,芳香醛-5-(2-羟基苯基)-1,3,4-噻二唑-2-硫基乙酰腙(4a～4h)比2-丁烯醛-5-(2-羟基苯基)-1,3,4-噻二唑-2-硫基乙酰腙(4i)有更好的抑菌活性.     

2-(4-甲硫苯氧基)-3-(4-甲苯基)-4H-咪唑啉-4-酮衍生物的合成及杀菌活性(Ⅱ)

用烯基膦亚胺与4-甲苯基异氰酸酯、对甲硫苯酚的串联aza-Wittig反应合成了2-(4-甲硫基苯氧基)-3-(4-甲苯基)-4H-咪唑啉-4-酮衍生物.探讨了反应进行的条件和产物的波谱性质,提出了可能的环化反应机理.生成的环化产物均为新的化合物,其结构经元素分析、IR、1H NMR和MS确证.并探讨了所合成的新型杂环化合物的生物活性,结果表明部分化合物表现出良好的抑菌活性,其中3f的活性最好,在质量分数为5×10-5浓度时,对稻瘟菌和苹果轮纹菌的抑制率均达到100%.     

2-甲氧亚胺基-2-(多取代苯基)乙酸甲酯类化合物合成及杀菌活性

以取代甲苯为原料,与草酰氯单甲酯反应生成傅克酰基化产物2-羰基-2-(邻甲基苯基)乙酸甲酯(A),A与甲氧基胺盐酸盐反应得到(Z/E)-2-(甲氧亚胺基)-2-(邻甲基苯基)乙酸甲酯(B),B与溴单质反应得到中间体(Z/E)-2-(2-溴甲基)苯基-2-甲氧亚胺基乙酸甲酯(C).E-2-甲氧亚胺基-(2-溴甲基苯基)乙酸甲酯(E)用硝酸硝化得到中间体E-2-甲氧亚胺基-(2-溴甲基-5-硝基苯基)乙酸甲酯(F).中间体C和F与芳香酮肟经过缩合反应生成甲氧亚胺基-(4或5-取代基-2-(1-(3或4-取代苯基)-E-亚乙基胺氧甲基)苯基)乙酸甲酯化合物(D,E和G),H可以从G1还原得到.所得新化合物均通过1H NMR,13C NMR,19F NMR,IR和HRMS等确证.用生长速率法测试了目标化合物对黄瓜灰霉、番茄早疫、小麦赤霉、辣椒疫霉、油菜菌核和水稻纹枯等6种真菌的离体抑菌活性.结果表明,部分目标化合物比肟菌酯有更高的杀菌活性.     

N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)酰胺类新化合物的合成及生物活性

以N-吡啶基吡唑甲酸和2-氨基-3-甲基苯甲酸为起始原料,经由亲核加成、环化和酰化等多步反应合成了一系列结构新颖的N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)酰胺类化合物.测试了所合成化合物的杀虫及抑菌活性,结果表明,新化合物大多化合物在200 mg·L^-1浓度下对东方粘虫(Mythimna separataWalker)具有一定的杀虫活性,尤其是N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)乙酰胺(8a)和N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)-3-氯-2,2-二甲基丙酰胺(8e)致死率可达70%;部分化合物在50 mg·L^-1浓度下对油菜菌核病菌的抑菌活性相对较好(54.5%~63.6%),优于triadimefon和chlorantraniliprole;部分化合物如N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)-3,3-二甲基丁酰胺80和N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)-4-氟苯甲酰胺(8h)对苹果轮纹病菌具有中等抑菌活性.值得注意的是,化合物8e的杀粘虫活性和对油菜菌核病菌的抑菌活性都较为突出,可用作新农药创制研究的新型参考结构.     

新型2-(2'-取代亚肼基)-1,3-二硫杂环戊烷衍生物的合成和菌活性研究

通过结构改造并结合活性基团的拼接合成了11个未见文献报道的新型2-(2'-取代亚肼基)-1,3-二硫杂环戊烷类化合物,所有的目标物的结构都经HNMR,MS,IR和元素分析证实,选择了其中5个化合物对7种细菌进行了抑菌活性1测试,并与市售农药20%三环唑、70%威尔达甲托的抑菌活性进行对比,发现它们比市售农药有更为广泛的杀菌谱,对照农药只对金黄色葡萄球菌有良好的抑菌作用而这些化合物则对所选择的七个菌种均有良好的抑菌作用.其中化合物2-(对氟苯氧乙酰亚肼基)-1,3-二硫杂环戊烷(4c)的杀菌谱很广,它对金色葡萄球菌、大肠杆菌、白色念珠菌的抑杀活性都很好.     

新型2-(2'-取代亚肼基)-1,3-二硫杂环戊烷衍生物的合成和菌活性研究

通过结构改造并结合活性基团的拼接合成了11个未见文献报道的新型2-(2'-取代亚肼基)-1,3-二硫杂环戊烷类化合物, 所有的目标物的结构都经¹H NMR, MS, IR和元素分析证实, 选择了其中5个化合物对7种细菌进行了抑菌活性测试, 并与市售农药20%三环唑、70%威尔达甲托的抑菌活性进行对比, 发现它们比市售农药有更为广泛的杀菌谱, 对照农药只对金黄色葡萄球菌有良好的抑菌作用而这些化合物则对所选择的七个菌种均有良好的抑菌作用. 其中化合物2-(对氟苯氧乙酰亚肼基)-1,3-二硫杂环戊烷(4c)的杀菌谱很广, 它对金色葡萄球菌、大肠杆菌、白色念珠菌的抑杀活性都很好.     

(E)-3-(1-亚胺基乙基)-5,5-二取代-4-甲氨基呋喃-2(5H)-酮的合成及其意外的杀虫活性（英文）

为了提高化合物对植物病原菌的杀菌活性及扩大多样性导向合成策略建立的分子库,以甲氨基替换3-(1-亚胺基乙基)-5,5-二取代-4-苯基呋喃-2(5H)-酮的苯基,设计合成了18个新颖的(E)-3-(1-亚胺基乙基)-5,5-二取代-4-甲氨基呋喃-2(5H)-酮,结构经过~1H NMR, ~(13)C NMR, HR-ESI-MS表征.(E)-3-(1-(4-甲氧基苄氧亚胺基)乙基)-4-甲氨基-1-氧杂螺[4.5]癸-3-烯-2-酮(5O)还经过X射线衍射表征.生物活性测试结果表明,所有化合物对测试的四种植物病原菌均未显示明显的活体杀菌活性,但是意外地发现多个化合物在600μg/mL浓度时对桃蚜、粘虫和小菜蛾的致死率均为100%,显示出良好的杀虫活性.     

N-(2-甲氧苯甲酰基)-N'-(4-甲苯并噻唑-2-基)硫脲的合成、晶体结构及抑菌活性

以邻甲氧基苯甲酸为原料合成新型化合物N-(2-甲氧苯甲酰基)-N’-(4-甲基苯并噻唑-2-基)硫脲,化合物结构经元素分析、IR、1H NMR表征,采用X-射线单晶衍射测定了其晶体结构,该晶体属于单斜晶系,P21/c空间群,晶胞参数a=0.79819(2)nm,b=1.44394(4)nm,c=1.45260(3)nm,β=92.793(2)°,V=1.67219(7)nm3,Dc=1.420Mg/m3,Z=4,F(000)=744,最终偏差因子R1=0.0373,wR2=0.0897[I2σ(I)],S=1.072,选择人体常见致病菌及广西主要经济作物(水稻、甘蔗、番茄、木薯、龙眼、荔枝)中常见的病原菌,对目标化合物进行室内抑菌活性测试,实验结果发现该化合物具有一定的抑菌活性。     

2-甲氧/乙氧羰基-4-氟苯基-1,5-苯并硫氮杂的合成、抑真菌活性及构效关系

以高活性的2-甲氧/乙氧羰基-4-(4-氟苯基)-1,5-苯并硫氮杂A和B为模型化合物,设计合成了11个含氟杂衍生物3a~3k,考察了它们对白色念珠菌和新生隐球菌的抑菌活性.研究结果表明,2-甲氧/乙氧羰基-4-(2-氟苯基)/(3-氟苯基)/(2,4-二氟苯基)-1,5-苯并硫氮杂3a,3b,3d~3f对新生隐球菌有很强的抑菌活性,3c的活性中等,而7位氯代杂3g~3k基本无活性;上述杂对白色念珠菌均无活性.在此基础上,进一步测试了高活性杂3a,3b,3d~3f对新生隐球菌的抑菌浓度梯度、最小抑菌浓度(MIC)和最小杀菌浓度(MFC),发现其MIC和MFC均远低于对照药氟康唑.为了考察杂3a~3f的药效基团,又设计合成了4类杂衍生物4a~4f,5a~5f,6a~6f和7a~7c,通过对其抑菌活性的评价,发现分子中2-甲氧/乙氧羰基和亚胺官能团对杂3a~3f的抑真菌(新生隐球菌)活性起关键作用,硫原子被氧原子或氮原子代替后原杂的活性降低.     

Preparation,molecular structures,and characteristic properties of (E)-1-(2-furyl)- and (E)-1-(2-thienyl)-2-(3-guaiazulenyl)ethylenes and (E)-1-(3-furyl)- and (E)-1-(3-thienyl)-2-(3-guaiazulenyl)ethylenes

Wittig reactions of 2-furaldehyde (20) [and thiophene-2-carbaldehyde (21)] with (3-guaiazulenylmethyl)triphenylphosphonium bromide (19) in ethanol containing NaOEt at 25 °C for 24 h under argon give (E)-1-(2-furyl)-2-(3-guaiazulenyl)ethylene (22E) and (E)-1-(2-thienyl)-2-(3-guaiazulenyl)ethylene (23E) in 53 and 36% yields. Similarly, Wittig reactions of 3-furaldehyde (29) [and thiophene-3-carbaldehyde (30)] with 19 under the same reaction conditions as for 20 and 21 afford (E)-1-(3-furyl)-2-(3-guaiazulenyl)ethylene (31E) and (E)-1-(3-thienyl)-2-(3-guaiazulenyl)ethylene (32E) in 32 and 46% yields. Molecular structures and characteristic properties as well as preparation of the title E (i.e., one of the geometrical isomers) forms, with a view to comparative study, are reported. Moreover, reactions of those conjugated π-electron systems with TCNE (=tetracyanoethylene) in benzene [and in DMF (=N,N-dimethylformamide)] at 25 °C for 24 h under argon yield unique products, possessing interesting molecular structures, respectively, whose characteristic properties and crystal structures are documented, also.     

First row transition metal complexes of (E)-2-(2-(2-hydroxybenzylidene) hydrazinyl)-2-oxo-N-phenylacetamide complexes

Manganese(II), iron(II), cobalt(II), nickel(II), copper(II), and chromium(III) complexes of (E)-2-(2-(2-hydroxybenzylidene)hydrazinyl)-2-oxo-N-phenylacetamide were synthesized and characterized by elemental and thermal (TG and DTA) analyses, IR, UV-vis and (1)H NMR spectra as well as magnetic moment. Mononuclear complexes are obtained with 1:1 molar ratio except [Mn(HOS)(2)(H(2)O)(2)] and [Co(OS)(2)](H(2)O)(2) complexes which are obtained with 1:2 molar ratios. The IR spectra of ligand and metal complexes reveal various modes of chelation. The ligand behaves as a monobasic bidentate one and coordination occurs via the enolic oxygen atom and azomethine nitrogen atom. The ligand behaves also as a monobasic tridentate one and coordination occurs through the carbonyl oxygen atom, azomethine nitrogen atom and the hydroxyl oxygen. Moreover, the ligand behaves as a dibasic tridentate and coordination occurs via the enolic oxygen, azomethine nitrogen and the hydroxyl oxygen atoms. The electronic spectra and magnetic moment measurements reveal that all complexes possess octahedral geometry except the copper complexes possesses a square planar geometry. From the modeling studies, the bond length, bond angle, HOMO, LUMO and dipole moment had been calculated to confirm the geometry of the ligands and their investigated complexes. The thermal studies showed the type of water molecules involved in metal complexes as well as the thermal decomposition of some metal complexes. The protonation constant of the ligand and the stability constant of metal complexes were determined pH-metrically in 50% (v/v) dioxane-water mixture at 298 K and found to be consistent with Irving-Williams order. Moreover, the minimal inhibitory concentration (MIC) of these compounds against Staphylococcus aureus, Escherechia coli and Candida albicans were determined.     

Bioanalysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine

(E)-5-(2-Bromovinyl)-2'-deoxyuridine is an antiviral drug that is experimentally used for modulation of the antitumour effect of fluoropyrimidines, such as ftorafur and 5-fluorouracil. The isolation of the analyte, in the presence of 5-fluorouracil, from the matrix is performed either by means of a simple protein precipitation (plasma) or by means of a liquid-liquid extraction with ethyl acetate (urine). Following pretreatment, the analyte is analysed by reversed-phase chromatography and quantified by absorbance detection at 307 nm. The minimum detectable concentration in plasma and urine samples is ca. 6 ng/ml. The recovery after deproteination of plasma samples is 75%, while after liquid-liquid extraction of urine the recovery amounts 92%. The degree of protein binding of the analyte, measured by ultrafiltration, is found to be 97%. These data allow the bioanalysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine for pharmacokinetic studies.